Evaluating anti-tumor activity of the human anti-PD-1 antibody pembrolizumab using humanized mouse models

被引：0
|
作者：
Linn, Douglas E.
Cristescu, Razvan
Ray, Kallol
Zhang, Shuli
Dhandapani, Sripriya
Kaliyaperumal, Sarav
Yearley, Jennifer H.
Long, Brian J.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1657
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1657
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-tumor effects of anti-PD-1 antibody, pembrolizumab, in humanized NSG PDX mice xenografted with dedifferentiated liposarcoma
    Choi, Bongkum
    Lee, Joo Sang
    Kim, Sung Joo
    Hong, Doopyo
    Park, Jae Berm
    Lee, Ki-Young
    CANCER LETTERS, 2020, 478 : 56 - 69
  • [2] Pharmacokinetics and immunogenicity of anti-PD-1 antibody in humanized FcRn mouse models compared to immunocompetent mouse models
    Tu, Xiaolong
    Feng, Xinhe
    Wang, Weifang
    Ding, Xunhua
    Huang, Dong
    Bourre, Ludo
    Chen, Xiaobo
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Anti-tumor activity of a novel anti-human PD-1 antibody BGB-A317 in mouse models
    Song, Xiaomin
    Tang, Zhiyu
    Zhang, Tong
    Guo, Mingming
    Gong, Wenfeng
    Liu, Yong
    Zhang, Ningning
    Zhang, Yilu
    Zhang, Yanjuan
    Ma, Jie
    Song, Jing
    Li, Kang
    Wang, Lai
    CANCER RESEARCH, 2016, 76
  • [4] Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model
    Li, Pan
    Rozich, Noah
    Wang, Jianxin
    Wang, Junke
    Xu, Yao
    Herbst, Brian
    Yu, Raymond
    Muth, Stephen
    Niu, Nan
    Li, Keyu
    Funes, Vanessa
    Gai, Jessica
    Osipov, Arsen
    Edil, Barish H.
    Wolfgang, Christopher L.
    Lei, Ming
    Liang, Tingbo
    Zheng, Lei
    CANCER LETTERS, 2022, 539
  • [5] A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
    Albu, Diana I.
    Wolf, Benjamin J.
    Qin, Yan
    Wang, Xianzhe
    Ulumben, Amy Daniel
    Su, Mei
    Li, Vivian
    Ding, Eirene
    Gonzalo, Jose Angel
    Kong, Jason
    Jadhav, Ruturaj
    Kuklin, Nelly
    Visintin, Alberto
    Gong, Bing
    Schuetz, Thomas J.
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [6] The efficacy of anti-PD-1 antibody for IVLBCL in humanized immune system mouse model
    Takai, Mika
    Shimada, Kazuyuki
    Kiyoi, Hitoshi
    CANCER SCIENCE, 2024, 115 : 1018 - 1018
  • [7] A novel humanized mouse model based on NOG-FcgR-/-mice recapitulates anti-tumor immune reactions by human immune systems in response to anti-PD-1 antibody (Nivolumab).
    Katano, Ikumi
    Hanazawa, Asami
    Otsuka, Iyo
    Yamaguchi, Takuya
    Mochiduki, Misa
    Kawai, Kenji
    Ito, Ryoji
    Goto, Motohito
    Kagawa, Takahiro
    Takahashi, Takeshi
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
    Naoto Kunimura
    Koichi Kitagawa
    Ryota Sako
    Keita Narikiyo
    Shoko Tominaga
    Diosdado S. Bautista
    Wei Xu
    Masato Fujisawa
    Toshiro Shirakawa
    Scientific Reports, 10
  • [9] Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
    Kunimura, Naoto
    Kitagawa, Koichi
    Sako, Ryota
    Narikiyo, Keita
    Tominaga, Shoko
    Bautista, Diosdado S.
    Xu, Wei
    Fujisawa, Masato
    Shirakawa, Toshiro
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [10] Anti-PD-1 antibody armored γδ T cells enhance anti-tumor efficacy in ovarian cancer
    Yue Wang
    Jingyi Han
    Dongdong Wang
    Menghua Cai
    Yi Xu
    Yu Hu
    Hui Chen
    Wei He
    Jianmin Zhang
    Signal Transduction and Targeted Therapy, 8
12345